SECTOR:

Ablaze Pharma

FUND/VEHICLE:

Pivotal China

INVESTMENT DATE:

2021

GEOGRAPHY:

China

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China.